De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma.
about
Alkaline ceramidase 2 (ACER2) and its product dihydrosphingosine mediate the cytotoxicity of N-(4-hydroxyphenyl)retinamide in tumor cellsCeramide synthases at the centre of sphingolipid metabolism and biologyEvolving concepts in cancer therapy through targeting sphingolipid metabolismA new mixed-backbone oligonucleotide against glucosylceramide synthase sensitizes multidrug-resistant tumors to apoptosisRadiation and Thyroid Cancer.Modulation of Insulin Sensitivity of Hepatocytes by the Pharmacological Downregulation of Phospholipase D.Tumor Necrosis Factor-α (TNFα)-induced Ceramide Generation via Ceramide Synthases Regulates Loss of Focal Adhesion Kinase (FAK) and Programmed Cell Death.Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer.Anticancer potential of sanguinarine for various human malignancies.Co-delivery of doxorubicin and PEGylated C16-ceramide by nanoliposomes for enhanced therapy against multidrug resistance.Purification and biochemical characterization of membrane-bound neutral ceramidase from camel brain (Camelus dromedarius).Extracellular matrix proteins modulate antimigratory and apoptotic effects of Doxorubicin.Bioluminescence imaging of caspase-3 activity in mouse liver.Therapeutic PEG-ceramide nanomicelles synergize with salinomycin to target both liver cancer cells and cancer stem cells.
P2860
Q24338765-978B07B1-99AE-4877-95DE-7902C42B45B2Q24609859-20AF9F1C-397B-4C93-8B9F-886DC03353ABQ26863646-2203AFD4-9D39-44D8-84BA-0B367BA4C20DQ28476087-E5F19C5B-A6A3-483E-A56B-BEBE155460B8Q33754785-62B29A33-BBC7-4C1D-87BA-36E1EAAC2494Q35690734-716C7491-0338-4788-B86B-744E883CD9E9Q36283299-3F1D8971-F5C6-4DEB-BA7B-CE671090854BQ37718254-5E5A71E4-0ED0-4361-9610-B8B7FA7DCAA2Q38052818-9DDCAA63-EFF8-458B-9040-257C24D783D9Q38668494-618056A7-97FD-4BF3-A37F-0FACEC7D41DCQ38862896-CF8E7B38-C2B5-47C7-A85C-7F7F1358D101Q39862757-455B57F5-5A9E-4F5B-BB79-3A93B383AE00Q41967456-37C354E5-63A1-4ABE-8848-F56AA854AE73Q42266433-328A0353-813F-444D-BBBF-F4AF65476912Q52876806-C0B7D0C4-5A51-42FB-9ECC-8A3D32B4C538
P2860
De novo ceramide synthesis is responsible for the anti-tumor properties of camptothecin and doxorubicin in follicular thyroid carcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
De novo ceramide synthesis is ...... follicular thyroid carcinoma.
@en
De novo ceramide synthesis is ...... follicular thyroid carcinoma.
@nl
type
label
De novo ceramide synthesis is ...... follicular thyroid carcinoma.
@en
De novo ceramide synthesis is ...... follicular thyroid carcinoma.
@nl
prefLabel
De novo ceramide synthesis is ...... follicular thyroid carcinoma.
@en
De novo ceramide synthesis is ...... follicular thyroid carcinoma.
@nl
P2093
P1476
De novo ceramide synthesis is ...... n follicular thyroid carcinoma
@en
P2093
Benoit Langlois
Geraldine Rath
Hamid Morjani
Hassan E L Btaouri
Hervé Sartelet
Laurent Martiny
P304
P356
10.1016/J.BIOCEL.2008.10.021
P577
2008-11-05T00:00:00Z